POU2AF1 anticorps (AA 148-255)

N° du produit ABIN7870761

L’anticorps anti-POU2AF1 Monoclonal Souris est utilisé pour la détection de POU2AF1 dans des échantillons de Humain. Il a été validé pour IHC (p).

Aperçu rapide pour POU2AF1 anticorps (AA 148-255) (ABIN7870761)

Antigène: POU2AF1 (POU Class 2 Associating Factor 1 (POU2AF1))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp POU2AF1 est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Classe de qualité: Carrier-free

Clone: BOB1-2423

Détail du produit anti-POU2AF1 anticorps

Épitope: AA 148-255

Fonction: BOB1 Antibody (azide and preservative free)

Purification: Protein G affinity

Immunogène: A portion of amino acids 148-255 from the human protein was used as the immunogen for the BOB1 antibody.

Isotype: IgG2b, kappa

Information d'application

Indications d'application: Optimal dilution of the BOB1 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: 4 °C,-20 °C

Stockage commentaire: Store the BOB1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Détails sur POU2AF1

Antigène: POU2AF1 (POU Class 2 Associating Factor 1 (POU2AF1))

Autre désignation: BOB1

Sujet: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity.

UniProt: Q16633